BIOCON
|
The Current P/B Ratio of BIOCON is 2.08.
Share Price | ₹305.2 | May 03,2024 |
Market Cap | ₹36,642.3 Cr | |
Book Value | ₹17,592.9 Cr | Mar2023 - Consolidated Results |
Price/Book | 2.08x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of BIOCON
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹36,642.3 Cr] as on May 03,2024
(/) Book Value [ ₹17,592.9 Cr] based on Mar2023 - Consolidated Results
(=) P/B Ratio [ 2.08x ]
Thus, for BIOCON , the investors are currently willing to pay '2.08 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of BIOCON !
The chart below summarizes the trend in P/B Ratio of BIOCON over the last five years.
Historical PB (Price/Book ) ratio chart of BIOCON
PB Ratio Performance Analysis for BIOCON
- BIOCON 's p/b ratio for fiscal years ending Mar2023 to Mar2019 averaged 4.77x.
- BIOCON 's operated at median p/b ratio of 4.92x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BIOCON 's p/b ratio peaked in Mar2021 at 6.57x.
- BIOCON 's p/b ratio hit its five-year low in Mar2023 of 1.41x.
How does BIOCON 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
BIOCON | 17,592.90 | 2.08 | 36,642.3 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 55,995.40 | 6.46 | 361,916.0 |
CIPLA LTD | 23,346.00 | 4.93 | 115,034.0 |
DR REDDYS LABORATORIES LTD | 23,140.40 | 4.58 | 105,929.0 |
ZYDUS LIFESCIENCES LTD | 17,515.80 | 5.73 | 100,322.0 |
DIVIS LABORATORIES LTD | 12,767.10 | 8.21 | 104,873.0 |
MANKIND PHARMA LTD | 7,435.16 | 12.47 | 92,708.2 |
TORRENT PHARMACEUTICALS LTD | 6,198.07 | 14.92 | 92,483.6 |
LUPIN LTD | 12,315.60 | 6.13 | 75,438.0 |
AUROBINDO PHARMA LTD | 26,839.80 | 2.52 | 67,541.1 |
ABBOTT INDIA LTD | 3,146.02 | 17.66 | 55,555.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs BIOCON 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.08x |
Max industry PB | 17.66x |
Median industry PB | 6.13x |
Average industry PB | 7.79x |
You may also like the below Video Courses